Skip to content

ALBANIMMO

Active
Private limited companyfounded 20169 yrs activeChée de la Libération 53, 1390 Grez-Doiceau, BelgiumKBO/BCE: BE 0667.765.123
Summary

ALBANIMMO has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.0m and a net result of €768,137. Equity is growing by ~4.3% per year across the filed fiscal years. Its solvency ranks better than 55% of 22026 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Risk analysisWatch ReportCompare
ALBANIMMOActiveChecked score 85/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
#9 company by equity in Grez-Doiceau, Wholesale and retail trade sector1 site
Size
€2.5mtotal assets 2025
Equity
€1.0m
Profit
€768,137
Financial health
85 Excellent Checked score 2025
Bankruptcy chance 12 m
0.6%
Structure
Parent
APOPHAR · 100%
Holdings
1
Accounts filed 22 d late0 of 4 deeds read
Why 85- Latest accounts 22 days late; 2 of the last 3 late- Liquidity: current ratio 1.75, cash €9,336, halved+ Size: total assets €2.5m+ Figures for FY 2025 (filed 22-08-2026)Show the evidence

Checked score

Score 2025
85 / 100
Excellent
Probability in this band: under 0.55%
Better than 79% of its sector peers (NACE 47, small)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 65+1
equity 39.7% of total assets
Liquidity 49+23
short-term debt 13.1% · cash 0.4%
Profitability 100+42
return on assets 30.4%
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (3,688 companies)
Last 24 months 11-2024: 1.7% 12-2024: 1.7%● 0.0% vs 11-2024 01-2025: 1.7%▼ -0.7% vs 12-2024 02-2025: 1.5%▼ -10.4% vs 01-2025 03-2025: 1.5%▼ -1.3% vs 02-2025 04-2025: 1.5%▲ +1.8% vs 03-2025 05-2025: 1.5%▼ -2.1% vs 04-2025 06-2025: 1.5%▲ +2.1% vs 05-2025 07-2025: 1.5%▼ -0.8% vs 06-2025 08-2025: 2.1%▲ +37.6% vs 07-2025 09-2025: 2.5%▲ +16.8% vs 08-2025 10-2025: 3.9%▲ +56.8% vs 09-2025highest value 11-2025: 0.9%▼ -77.4% vs 10-2025 12-2025: 0.9%● 0.0% vs 11-2025 01-2026: 0.9%▼ -1.4% vs 12-2025 02-2026: 0.9%▲ +0.7% vs 01-2026 03-2026: 0.9%▲ +1.6% vs 02-2026 04-2026: 0.9%● 0.0% vs 03-2026 05-2026: 0.9%▲ +4.1% vs 04-2026 06-2026: 0.9%▼ -2.7% vs 05-2026 07-2026: 0.9%▲ +2.5% vs 06-2026 08-2026: 1.3%▲ +42.1% vs 07-2026 09-2026: 0.6%▼ -57.7% vs 08-2026lowest value 10-2026: 0.6%● 0.0% vs 09-2026lowest value
  • Latest accounts 22 days late; 2 of the last 3 late raises the probability
  • Size: total assets €2.5m lowers the probability for this profile
  • Liquidity: current ratio 1.75, cash €9,336, halved raises the probability
  • Figures for FY 2025 (filed 22-08-2026) lowers the probability
Credit up to €85,000 at 30 days acceptable
Liquidity ample (current ratio 1.75 against 0.14 in 2024; short-term debt: 13.1% and cash: 0.4% of total assets), but 60.3% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, small). Better than this share of them on solvency 61%, liquidity 59%, profitability 98%, growth against the median 98%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 04-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Latest accounts 22 days late; 2 of the last 3 late
In the bankruptcy model this factor raises the probability.
NBB · filings
lowers risk · Size: total assets €2.5m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
raises risk · Liquidity: current ratio 1.75, cash €9,336, halved
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Figures for FY 2025 (filed 22-08-2026)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-08-2026, 22 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 9 filings
Deviation from the deadline
2025
22 d late
2024
59 d late
2023
76 d late
2022
147 d late
2021
31 d late
2020
17 d late
2019
31 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 55 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 28 September (4 of the last 5 filed years within 37 days of that day).
Companies Code · seven months
Position in the running window
05-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Highest result since 2018net €768,137 ▲19,429%
  3. Liquidity times 12current ratio 1.75

Key points

  • Positive: Result rose in 2025from €3,933 to €768,137 ▲ 19,429% View
  • Positive: Among the best 5% on net resultsector median €5,036 · 22,005 companies €768,137 View
  • Controlled by APOPHAR 100% View

By topic

Financials

Fiscal year
2025
Total assets
€2.5m
Profit
€768,137
Solvency
39.7%
Total assets▲ 321%
Net result
20182025
Go to Financials

Timeline

Events
16
Since
2018
Next accounts
by 31-07-2027
  1. 22-08-2026Annual accounts filed
  2. 31-12-2025Highest result since 2018
  3. 31-12-2025Liquidity times 12
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
15-12-2016
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure